Brought to you by 
Drais gets rights to Unibioscreen's cancer candidate
16 Sep 2008
Executive Summary
Drug development start-up Drais Pharmaceuticals has licensed exclusive worldwide development and commercialization rights to Unibioscreen SA's (oncology treatments derived from plants or marine invertebrates) UNBS5162 for cancer.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Drais gets rights to Unibioscreen's cancer candidate
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice